In this issue:
Topical calcineurin inhibitors and keratinocyte carcinoma risk in AD
Comprehensive skin toxicity programme for EGFR inhibitor recipients
SARS-CoV-2 endothelial infection causes COVID-19 chilblains
Cost-effectiveness of field-directed treatments for AK of the head/neck
Imiquimod cream for BCCs
Topical hydrogen peroxide for common warts
Postsurgery superficial x-ray of keloids to prevent recurrence
PCR-based T-cell receptor-β clonality assays for early mycosis fungoides diagnosis
Clascoterone for androgenetic alopecia
Capecitabine for treatment/prevention of AKs, SCCs and BCCs
Please login below to download this issue (PDF)